Standard Biotools | FLDM - Operating Profit


Standard Biotools reported $-23.47M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Agilent USD 443M 66M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Bio-Rad Laboratories USD 77.1M 53.4M Jun/2025
Bruker USD 83.9M 72M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Illumina USD 250M 5M Sep/2025
Myriad Genetics USD -23.3M 10.8M Sep/2025
Nikon Corporation JPY -3.64B 2.45B Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Sony JPY -1.67T 236.35B Sep/2025
Standard Biotools USD -23.47M 230K Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Waters USD 192.11M 3.9M Sep/2025